, Volume 18, Issue 4, pp 278–298 | Cite as

Drugs and Vitamin Deficiency

  • Lars Ovesen
Review Article


During the past 10 to 20 years it has become increasingly clear that a certain number of drugs may lead to increased vitamin requirements. However, it is unusual for symptomatic avitaminosis to develop, and then only when circumstances are present which in themselves increase the risk of vitamin deficiency.

Therapeutic doses of drugs will interfere with the vitamin status only to a restricted degree, provided they are administered for brief periods and to patients receiving a normal supply of vitamins. Most cases of vitamin deficiency have in fact been described in connection with drugs usually taken for a longer period of time by patients who were already in negative vitamin balance as a result of disease or marginal supply of the necessary vitamins. This review describes some of the more important articles covering this topic.


Oral Contraceptive Isoniazid Osteomalacia Pyrimethamine Vitamin Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, P.W.; Folkard, J.; Wynn, V. and Seed, M.: Influence of oral contraception, pyridoxine (vitamin B6), and tryptophan on carbohydrate metabolism. Lancet 1: 759–764 (1976).PubMedGoogle Scholar
  2. Adams, P.W.; Rose, D.P.; Folkard, J.; Seed, M. and Strong, R.: Effect of pyridoxine hydrochloride (vitamin ?6) upon depression associated with oral contraception. Lancet 1: 897–904 (1973).Google Scholar
  3. Adams, P.W.; Wynn, V.; Seed, M. and Folkard, J.: Vitamin B6, depression and oral contraception. Lancet 2: 516–517 (1974).PubMedGoogle Scholar
  4. Ahmed, F.; Bamji, M.S. and Iyengar, L.: Effect of oral contraceptive agents on vitamin nutrition status. American Journal of Clinical Nutrition 28: 606–615 (1975).PubMedGoogle Scholar
  5. Alter, H.J.; Zvaifler, N.J. and Rath, C.E.: Interrelationship of rheumatoid arthritis, folic acid, and aspirin. Blood 38: 405–416 (1971).PubMedGoogle Scholar
  6. Basu, T.K. and Dickerson, J.W.T.: Inter-relationships of nutrition and the metabolism of drugs. Chemico-Biological Interactions 8: 193–206 (1974).PubMedGoogle Scholar
  7. Biehl, J.P. and Vilter, R.W.: Effects of isoniazid on pyridoxine metabolism. Journal of the American Medical Association 156: 1549–1552 (1954).PubMedGoogle Scholar
  8. Borgstedt, A.D.; Bryson, M.F.; Young, L.W. and Forbes, G.B.: Long-term administration of antiepileptic drugs and the development of rickets. Journal of Pediatrics 81: 9–15 (1972).PubMedGoogle Scholar
  9. Borrie, P. and Clark, P.A.: Megaloblastic anaemia during methotrexate treatment of psoriasis. British Medical Journal 1: 1339 (1966).PubMedGoogle Scholar
  10. Braidman, I.P. and Rose, D.P.: Effects of sex hormones on three glucocorticoid-inducible enzymes concerned with amino acid metabolism in rat liver. Endocrinology 89: 1250–1255 (1971).PubMedGoogle Scholar
  11. Brain, M.C. and Booth, C.C.: The absorption of tritium-labelled pyridoxine HCl in control subjects and in patients with intestinal malabsorption. Gut 5: 241–247 (1964).PubMedGoogle Scholar
  12. Briggs, M. and Briggs, M.: Vitamin C and colds. Lancet 1: 998 (1973).PubMedGoogle Scholar
  13. Briggs, M.H. and Briggs, M.: Thiamine status and oral contraceptives. Contraception 11: 151–153 (1975a).PubMedGoogle Scholar
  14. Briggs, M.H. and Briggs, M.: Ascorbic acid and the pill. Chemistry in Britain 11: 74 (1975b).Google Scholar
  15. Carruthers, M.E.; Hobbs, C.B. and Warren, R.L.: Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives. Journal of Clinical Pathology 19: 498–500 (1966).PubMedGoogle Scholar
  16. Chanarin, I. and England, J.M.: Toxicity of trimethoprim-sulphamethoxazole in patients with megaloblastic haemopoiesis. British Medical Journal 1: 651 (1972).PubMedGoogle Scholar
  17. Child, J.A.; Khattak, B.Z. and Knowles, J.P.: Macrocytosis in patients on anticonvulsant drugs. British Journal of Haematology 16: 451–455 (1969).PubMedGoogle Scholar
  18. Christiansen, C. and Rodbro, P.: Effect of vitamin D2 on serum Phenytoin. A controlled therapeutic trial. Acta Neurologica Scandinavica 50: 661–664 (1974).PubMedGoogle Scholar
  19. Christiansen, C; Rodbro, P. and Lund, M.: Incidence of anticonvulsant osteomalacia and effect of vitamin D.: Controlled therapeutic trial. British Medical Journal 4: 695–701 (1973).PubMedGoogle Scholar
  20. Christiansen, C; Rodbro, P. and Sjo, O.: ‘Anticonvulsant action’ of vitamin D in epileptic patients? A controlled pilot study. British Medical Journal 2: 258–259 (1974).PubMedGoogle Scholar
  21. Cobum, J.W.; Hartenbower, D.L. and Brickman, A.S.: Advances in vitamin D metabolism as they pertain to chronic renal disease. American Journal of Clinical Nutrition 29: 1283–1299 (1976).Google Scholar
  22. Corcino, J.; Waxman, S. and Herbert, V.: Mechanism of triamterene-induced megaloblastosis. Annals of Internal Medicine 73: 419–424 (1970).PubMedGoogle Scholar
  23. Coronato, A. and Glass, G.B.J.: Depression of the intestinal uptake of radio-vitamin B12 by cholestyramine. Proceedings of the Society of Experimental Biology and Medicine 142: 1341–1344 (1973).Google Scholar
  24. DaCosta, M. and Rothenberg, S.P.: Appearance of a folate binder in leukocytes and serum of women who are pregnant or taking oral contraceptives. Journal of Laboratory and Clinical Medicine 83: 207–214 (1974).Google Scholar
  25. DeLuca, H.F.: Metabolism of vitamin D.: Current status. American Journal of Clinical Nutrition 29: 1258–1270 (1976).PubMedGoogle Scholar
  26. Dent, C.E.; Richens, A.; Rowe, D.J.F. and Stamp, T.C.B.: Osteomalacia with long-term anticonvulsant therapy in epilepsy. British Medical Journal 4: 69–72 (1970).PubMedGoogle Scholar
  27. Devadatta, S.; Gangadharam, P.R.J.; Andrews, R.H.; Fox, W.; Ramakrishnan, C.V.; Selkon, J.B. and Velu, S.: Peripheral neuritis due to isoniazid. Bulletin of the World Health Organization 23: 587–598 (1960).PubMedGoogle Scholar
  28. Dietrich, L.S.: Regulation of nicotinamide metabolism. American Journal of Clinical Nutrition 24: 800–804 (1971).Google Scholar
  29. Faloon, W.W.: Metabolic effects of nonabsorbable antibacterial agents. American Journal of Clinical Nutrition 23: 645–651 (1970).PubMedGoogle Scholar
  30. Fausa, O.: Salicylate-induced hypoprothrombinemia. Acta Medica Scandinavica 188: 403–408 (1970).PubMedGoogle Scholar
  31. Fingl, E.: Laxatives and cathartics; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, p.978 (MacMillan Publishing Co. Inc.; New York 1975).Google Scholar
  32. Frame, B.; Guiang, H.L.; Frost, H.M. and Reynolds, W.A.: Osteomalacia induced by laxative (Phenolphthalein) ingestion. Archives of Internal Medicine 128: 794–796 (1971).PubMedGoogle Scholar
  33. Franklin, J.L. and Rosenberg, I.H.: Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (azulfidine). Gastroenterology 64: 517–525 (1973).PubMedGoogle Scholar
  34. Gershoff, S.N.: Vitamin B6; in Present Knowledge in Nutrition, pp. 141–161 (The Nutrition Foundation Inc.; New York, Washington 1976).Google Scholar
  35. Giroud, A.: Nutritional requirements of the embryo. World review of Nutrition and Dietetics 18: 195–262 (1973).PubMedGoogle Scholar
  36. Golden, R.L.; Mortati, F.S. and Schroeter, G.A.: Levodopa, pyridoxine, and the burning feet syndrome. Journal of the American Medical Association 213: 628 (1970).PubMedGoogle Scholar
  37. Gordon, N.: Folic acid deficiency from anticonvulsant therapy. Developmental Medicine and Child Neurology 10: 497–504 (1968).PubMedGoogle Scholar
  38. Green, J.D.: Megaloblastic anemia in a vegetarian taking oral contraceptives. Southern Medical Journal 68: 249–250 (1975).PubMedGoogle Scholar
  39. Greenwood, R.H.; Prunty, F.T.G. and Silver, J.: Osteomalacia after prolonged glutethimide administration. British Medical Journal 1: 643–645 (1973).PubMedGoogle Scholar
  40. Griffiths, W.A.D.: Isoniazid-induced pellagra. Proceedings of the Royal Society of Medicine 69: 313–314 (1976).PubMedGoogle Scholar
  41. Haghshenass, M. and Dodda, B.: Serum folate levels during anticonvulsant therapy with diphenylhydantoin. Journal of the American Geriatric Society 21: 275–277 (1973).Google Scholar
  42. Hahn, T.J.: Bone complications of anticonvulsants. Drugs 12: 201–211 (1976).PubMedGoogle Scholar
  43. Hahn, T.J.; Birge, S.J.; Scharp, C.R. and Avioli, L.V.: Phenobar-bital-induced alterations in vitamin D metabolism in mammals. Journal of Clinical Investigation 51: 741–748 (1972a).PubMedGoogle Scholar
  44. Hahn, T.J.; Hendin, B.A.; Scharp, C.R.; Boisseau, V.C. and Haddad, J.G.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. New England Journal of Medicine 292: 550–554 (1975).Google Scholar
  45. Hahn, T.J.; Hendin, B.A.; Scharp, C.R. and Haddad, J.G.: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. New England Journal of Medicine 287: 900–904 (1972b).PubMedGoogle Scholar
  46. Heaton, K.W.; Lever, J.V.; Path, M.R.C and Barnard, D.: Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea. Gastroenterology 62: 642–646 (1972).PubMedGoogle Scholar
  47. Heinivaara, O. and Palva, I.: Para-aminosalisyylihapon aiheuttama megaloblastinen anemia. Duodecim 79: 945–946 (1963).PubMedGoogle Scholar
  48. Hollander, D.: Vitamin K1 absorption by everted intestinal sacs of the rat. American Journal of Physiology 226: 360–364 (1973).Google Scholar
  49. Hollander, D. and Truscott, T.C: Mechanism and site of vitamin K-3 small intestinal transport. American Journal of Physiology 226: 1516–1522 (1974).PubMedGoogle Scholar
  50. Hunter, J.; Maxwell, J.D.; Stewart, D.A.; Parsons, V. and Williams, R.: Altered calcium metabolism in epileptic children on anticonvulsants. British Medical Journal 4: 202–204 (1971).PubMedGoogle Scholar
  51. Jacobson, E.D.; Chodos, R.B. and Faloon, W.W.: An experimental malabsorption syndrome induced by neomycin. American Journal of Medicine 28: 524–533 (1960).PubMedGoogle Scholar
  52. Jaffe, I.A.: Antivitamin B6 effect of D-penicillamine. Annals New York Academy of Sciences 166: 57–60 (1969).Google Scholar
  53. Jewkes, R.F.; Edwards, M.S. and Grant, B.J.B.: Haematological changes in a patient on long-term treatment with a trimethoprim-sulphonamide combination. Postgraduate Medical Journal 46: 723–726 (1970).PubMedGoogle Scholar
  54. Johnson, K.G.; Greenen, J.E.; Hensley, G.T. and Soergel, K.H.: Small intestinal disease, folate deficiency anemia, and oral contraceptive agents. Digestive Diseases 18: 185–190 (1973).Google Scholar
  55. Kahn, S.B.; Fein, S.A. and Brodsky, I.: Effects of trimethoprim on folate metabolism in man. Clinical Pharmacology and Therapeutics 9: 550–560 (1968).PubMedGoogle Scholar
  56. Kirkendall, W.M. and Page, E.B.: Polyneuritis occurring during hydralazine therapy. Journal of the American Medical Association 167: 427–432 (1958).PubMedGoogle Scholar
  57. Koch-Weser, J.: Quinidine-induced hypoprothrombinemic hemorrhage in patients on chronic warfarin therapy. Annals of Internal Medicine 68: 511–517 (1968).PubMedGoogle Scholar
  58. Klipstein, F.A.: Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy. Blood 23: 68–86 (1964).PubMedGoogle Scholar
  59. Kruse, R.: Osteopathien bei antiepileptischer Langzeittherapie (vorlaufige Mitteilung). Monatsschrift fur Kinderheilkunde 116: 378–381 (1968).PubMedGoogle Scholar
  60. Levine, R.A.: Effect of dietary gluten upon neomycin-induced malabsorption. Gastroenterology 52: 685–690 (1967).PubMedGoogle Scholar
  61. Lifshitz, F. and Maclaren, N.K.: Vitamin D-dependent rickets in institutionalised, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. Journal of Pediatrics 83: 612–620 (1973).PubMedGoogle Scholar
  62. Lindenbaum, J.; Whitehead, N. and Reyner, F.: Oral contraceptive hormones, folate metabolism, and the cervical epithelium. American Journal of Clinical Nutrition 28: 346–353 (1975).PubMedGoogle Scholar
  63. Livingston, S.; Berman, W. and Pauli, L.L.: Anticonvulsant drugs and vitamin D metabolism. Journal of the American Medical Association 224: 1634–1635 (1973).PubMedGoogle Scholar
  64. Loh, H.S.; Watters, K. and Wilson, C.W.M.: The effects of aspirin on the metabolic availability of ascorbic acid in human beings. Journal of Clinical Pharmacology 13: 480–486 (1973).PubMedGoogle Scholar
  65. Long, R.G.; Skinner, R.K.; Wills, M.R. and Sherlock, S.: Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet 2: 650–652 (1976).PubMedGoogle Scholar
  66. Lumeng, L.; Cleary, R.E. and Li, T.-K.: Effect of oral contraceptives on the plasma concentration of pyridoxal phosphate. American Journal of Clinical Nutrition 27: 326–333 (1974).PubMedGoogle Scholar
  67. McCurdy, P.R. and Donohoe, R.F.: Pyridoxine-responsive anemia conditioned by isonicotinic acid hydrazide. Blood 27: 352–362 (1966).PubMedGoogle Scholar
  68. McKenzie, S.A.; Macnab, A.J. and Katz, G.: Neonatal pyridoxine responsive convulsions due to isoniazid therapy. Archives of Disease in Childhood 51: 567–568 (1976).PubMedGoogle Scholar
  69. McLeroy, V.J. and Schendel, H.E.: Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women. American Journal of Clinical Nutrition 26: 191–196 (1973).PubMedGoogle Scholar
  70. Markkanen, T.; Virtanen, S.; Pajula, R.-L. and Himanen, P.: Hormonal dependence of folic acid protein binding in human serum. International Journal for Vitamin and Nutrition Research 44: 81–94 (1974).PubMedGoogle Scholar
  71. Mason, M.; Ford, J. and Wu, H.L.C.: Effects of steroid and nonsteroid metabolites on enzyme conformation and pyridoxal phosphate binding. Annals of New York Academy of Sciences 166: 170–183 (1969).Google Scholar
  72. Mattson, R.H.; Gallagher, B.B.; Reynolds, E.H. and Glass, D.: Folate therapy in epilepsy. Archives of Neurology 29: 78–81 (1973).PubMedGoogle Scholar
  73. Maxwell, J.D.; Hunter, J.; Stewart, D.A.; Ardeman, S. and Williams, R.: Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction. British Medical Journal 1: 297–299 (1972).PubMedGoogle Scholar
  74. Meulengracht, E.: Osteomalacia of the spinal column from deficient diet or from disease of the digestive tract. III. Osteomalacia e abuse laxantium. Acta Medica Scandinavica 101: 187–210 (1939).Google Scholar
  75. Mosekilde, L.; Christensen, M.S.; Lund, B.; Sorensen, O.H. and Meisen, F.: The interrelationships between serum 25-hydroxy-cholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia. Acta Endocrinologica 84: 559–565 (1977).PubMedGoogle Scholar
  76. Mountain, K.R.; Hirsh, J. and Gallus, A.S.: Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet 1: 265–268 (1970).PubMedGoogle Scholar
  77. Newman, L.J.; Lopez, R.; Cole, H.S.; Boria, M.C. and Cooperman, J.M.: Riboflavin deficiency in women taking oral contraceptive agents. American Journal of Clinical Nutrition 31: 247–249 (1978).PubMedGoogle Scholar
  78. O’Reilly, R.A. and Aggeler, P.M.: Determinants of the response to oral anticoagulant drugs in man. Pharmacological Reviews 22: 35–96 (1970).PubMedGoogle Scholar
  79. Osaki, S.; McDermott, J.A. and Frieden, E.: Proof for the ascor-bate oxidase activity of ceruloplasmin. Journal of Biological Chemistry 239: 3570–3575 (1964).PubMedGoogle Scholar
  80. Paine, C.J.; Grafton, W.D.; Dickson, V.L. and Eichner, E.R.: Oral contraceptives, serum folate, and hematologic status. Journal of the American Medical Association 231: 731–733 (1975).PubMedGoogle Scholar
  81. Palva, I.P.; Heinivaara, O. and Mattila, M.: Drug-induced malabsorption of vitamin B12. III. Interference of PAS and folic acid in the absorption of vitamin B12. Scandinavian Journal of Haematology 3: 149–153 (1966).PubMedGoogle Scholar
  82. Palva, I.P.; Salokannel, S.J.; Timonen, T. and Palva, H.L.A.: Drug-induced malabsorption of vitamin B12. IV. Malabsorption and deficiency of B12 during treatment with slow-release potassium chloride. Acta Medica Scandinavica 191: 355–357 (1972).PubMedGoogle Scholar
  83. Pylypchuk, G; Oreopoulos, D.G; Wilson, D.R.; Harrison, J.E.; McNeill, K.G; Melma, H.E.; Ogilvie, R.; Sturbridge, W.C and Murray, T.M.: Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy. Canadian Medical Association Journal 118: 635–638 (1978).PubMedGoogle Scholar
  84. Race, T.F.; Pace, I.C. and Faloon, W.W.: Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. American Journal of the Medical Sciences 259: 32–41 (1970).PubMedGoogle Scholar
  85. Reynolds, E.H.: Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. Lancet 1: 1086–1088 (1967).PubMedGoogle Scholar
  86. Reynolds, E.H.: Iatrogenic nutritional effects of anticonvulsants. Proceedings of the Nutrition Society 33: 225–229 (1974).PubMedGoogle Scholar
  87. Reynolds, E.H.; Milner, G; Matthews, D.M. and Chanarin, I.: Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism. Q. J. Med. 35: 521–537 (1966).Google Scholar
  88. Richens, A. and Rowe, D.J.F.: Disturbance of calcium metabolism by anticonvulsant drugs. British Medical Journal 4: 73–76 (1970).PubMedGoogle Scholar
  89. Rivers, J.M.: Oral contraceptives and ascorbic acid. American Journal of Clinical Nutrition 28: 550–554 (1975).PubMedGoogle Scholar
  90. Rodbro, P.; Christiansen, C. and Lund, M.: Development of anticonvulsant osteomalacia in epileptic patients on Phenytoin treatment. Acta Neurologica Scandinavica 50: 527–532 (1974).PubMedGoogle Scholar
  91. Roels, O.A.: Vitamin A physiology. Journal of the American Medical Association 214: 1097–1102 (1970).PubMedGoogle Scholar
  92. Rose, D.P. and Adams, P.W.: Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of low-dose progestagen (megestrol acetate) given alone. Journal of Clinical Pathology 25: 252–258 (1972).PubMedGoogle Scholar
  93. Rose, D.P.; Strong, R.; Adams, P.W. and Harding, P.E.: Experimental vitamin B6 deficiency and the effect of oestrogen-containing oral contraceptives on tryptophan metabolism and vitamin B6 requirements. Clinical Science 42: 465–477 (1972).PubMedGoogle Scholar
  94. Rosenberg, I.H. and Godwin, H.A.: The digestion and absorption of dietary folate. Gastroenterology 60: 445–463 (1971).PubMedGoogle Scholar
  95. Rostand, S.G: Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis. American Journal of Clinical Nutrition 29: 691–697 (1976).PubMedGoogle Scholar
  96. Sahud, M.A.: Uptake and reduction of dehydroascorbic acid in human platelets. Clinical Research 18: 133 (1970).Google Scholar
  97. Sahud, M.A. and Cohen, R.J.: Effect of aspirin ingestion on ascorbic-acid levels in rheumatoid arthritis. Lancet 1: 937–939 (1971).PubMedGoogle Scholar
  98. Saroja, N.; Mallikarjuneswara, V.R. and Clemetson, C.A.B.: Effect of estrogens on ascorbic acid in the plasma and blood vessels of guinea pigs. Contraception 3: 269–277 (1971).Google Scholar
  99. Schmid, F.: Osteopathien bei antiepileptischer Dauerbehandlung. Fortschritte der Medizin 85: 381–383 (1967).Google Scholar
  100. Shojania, A.M. and Hornady, G.J.: Oral contraceptives and folate absorption. Journal of Laboratory and Clinical Medicine 82: 869–875 (1973).PubMedGoogle Scholar
  101. Shojania, A.M.; Hornady, G.J. and Barnes, P.H.: The effect of oral contraceptives on folate metabolism. American Journal of Obstetrics and Gynecology 111: 782–791 (1971).PubMedGoogle Scholar
  102. Silver, J.; Neale, G and Thompson, G.R.: Effect of phenobarbitone treatment on vitamin D metabolism in mammals. Clinical Science and Molecular Medicine 46: 433–448 (1974).PubMedGoogle Scholar
  103. Sinclair, L.: Rickets from liquid paraffin. Lancet 1: 792 (1967).PubMedGoogle Scholar
  104. Solomon, G.E.; Hilgartner, M.W. and Kutt, H.: Coagulation defects caused by diphenylhydantoin. Neurology 22: 1165–1 175 (1972).PubMedGoogle Scholar
  105. Stamp, T.C.B.: Effects of long-term anticonvulsant therapy on calcium and vitamin D metabolism. Proceedings of the Royal Society of Medicine 67: 64–68 (1974).PubMedGoogle Scholar
  106. Stenflo, J.: Vitamin K, prothrombin and gamma-carboxyglutamic acid. New England Journal of Medicine 296: 624–626 (1977).PubMedGoogle Scholar
  107. Stevenson, N.R. and Brush, M.K.: Existence and characteristics of Na+-dependent active transport of ascorbic acid in guinea pig. American Journal of Clinical Nutrition 22: 318–326 (1969).PubMedGoogle Scholar
  108. Streiff, R.R.: Folate deficiency and oral contraceptives. Journal of the American Medical Association 214: 105–108 (1970).PubMedGoogle Scholar
  109. Strickland, G.T. and Kostinas, J.E.: Folic acid deficiency complicating malaria. American Journal of Tropical Medicine and Hygiene 19: 910–915 (1970).PubMedGoogle Scholar
  110. TenPas, A. and Abraham, J.P.: Hematological side-effects of pyrimethamine in the treatment of ocular toxoplasmosis. American Journal of the Medical Sciences 249: 448–453 (1965).PubMedGoogle Scholar
  111. Tomkin, G.H.: Malabsorption of vitamin B12 in diabetic patients treated with phenformin: a comparison with metformin. British Medical Journal 3: 673–675 (1973).PubMedGoogle Scholar
  112. Tomkin, G.H.; Hadden, D.R.; Weaver, J.A. and Montgomery, D.A.D.: Vitamin B12 status of patients on long-term metformin therapy. British Medical Journal 2: 685–687 (1971).PubMedGoogle Scholar
  113. Visintine, R.E.; Michaels, G.D.; Fukayama, G.; Conklin, J. and Kinsell, L.W.: Xanthomatous biliary cirrhosis treated with cholestyramine. Lancet 2: 341–343 (1961).PubMedGoogle Scholar
  114. Waxman, S.; Corcino, J.J. and Herbert, V.: Drugs, toxins, and dietary amino acids affecting vitamin B12 or folic acid absorption or utilization. American Journal of Medicine 48: 599–608 (1970).PubMedGoogle Scholar
  115. Wertalik, L.F.; Metz, E.N.; LoBuglio, A.F. and Balcerzak, S.P.: Decreased serum B12 levels with oral contraceptive use. Journal of the American Medical Association 221: 1371–1374 (1972).PubMedGoogle Scholar
  116. West, J. and Lloyd, J.K.: The effect of cholestyramine on intestinal absorption. Gut 16: 93–98 (1975).PubMedGoogle Scholar
  117. Windsor, A.C.M.; Hobbs, C.B.; Treby, D.A. and Astley Cowper, R.: Effect of tetracycline on leucocyte ascorbic acid levels. British Medical Journal 1: 214–215 (1972).PubMedGoogle Scholar
  118. Wood, J.K.; Goldstone, A.H. and Allan, N.C.: Folic acid and the pill. Scandinavian Journal of Haematology 9: 539–544 (1972).PubMedGoogle Scholar
  119. Wynn, V.; Adams, P.W.; Folkard, J. and Seed, M.: Tryptophan, depression and steroidal contraception. Journal of Steroid Biochemistry 6: 965–970 (1975).PubMedGoogle Scholar

Copyright information

© ADIS Press Australasia Pty Ltd 1979

Authors and Affiliations

  • Lars Ovesen
    • 1
  1. 1.Clinical Nutrition ProgramAlbany Medical CollegeAlbanyUSA

Personalised recommendations